Literature DB >> 10414499

Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities.

B F Skinnider1, D E Horsman, B Dupuis, R D Gascoyne.   

Abstract

The bcl-2 gene on chromosome 18 at q21 and the bcl-6 gene on chromosome 3 at q27 are both highly regulated during B-cell differentiation and show an inverse relationship of expression in the normal secondary lymphoid follicle. The objective of this study was to investigate the relationship between bcl-2 and bcl-6 protein expression and the relationship between protein expression and the corresponding chromosomal alterations in malignant lymphomas, including those associated with the germinal center. Expression of bcl-2 and bcl-6 proteins was studied in 55 cases of diffuse large B-cell lymphoma (DLBCL) and 21 cases of follicular lymphoma (FL), and the results correlated with the presence of t(14;18) and 3q27 abnormalities in a subset of 52 cases with cytogenetic analysis. These cases were selected to represent a spectrum of nodal and extranodal lymphomas, including those with and without a t(14;18). It was shown that the neoplastic cells in 71% of DLBCLs and 100% of FLs expressed bcl-6 protein. Expression of bcl-6 was seen more frequently in diffuse large B-cell lymphomas with large noncleaved morphology compared with immunoblastic morphology (82% v 27%, P = .0015), but failed to correlate with 3q27 abnormalities. Thirty-eight percent of cases with 3q27 abnormalities were bcl-6 protein negative, whereas 85% of cases without a 3q27 abnormalities were bcl-6 protein positive. Expression of bcl-2 protein was shown in 51% DLBCLs (nodal v extranodal, 71% v 30%, P = .012). bcl-2 protein was expressed in 89% of FLs with t(14;18), in contrast to 25% of FLs without t(14;18) (P = .016). In DLBCL and FL with t(14;18), the most common pattern of expression was bcl-2+/bcl-6+. In lymphomas without t(14;18), there was not an inverse relationship between bcl-2 and bcl-6 protein expression. In conclusion, these data suggest that mechanisms other than gene rearrangements can deregulate bcl-2 and bcl-6 expression in lymphomas, and there does not appear to be an inverse relationship between these two proteins as seen in the normal germinal center.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414499     DOI: 10.1016/s0046-8177(99)90141-7

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

Review 1.  Detection of BCL2 rearrangements in follicular lymphoma.

Authors:  Jon C Aster; Janina A Longtine
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma.

Authors:  Murali Janakiram; Venu K Thirukonda; Matthew Sullivan; Adam M Petrich
Journal:  Curr Treat Options Oncol       Date:  2012-02-02

3.  Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.

Authors:  Akiko Miyagi Maeshima; Hirokazu Taniguchi; Suguru Fukuhara; Noriyuki Morikawa; Wataru Munakata; Dai Maruyama; Sung-Won Kim; Takashi Watanabe; Yukio Kobayashi; Kensei Tobinai; Hitoshi Tsuda
Journal:  Cancer Sci       Date:  2012-08-14       Impact factor: 6.716

Review 4.  Nodal aggressive B-cell lymphomas: a diagnostic approach.

Authors:  Sonam Prakash; Steven H Swerdlow
Journal:  J Clin Pathol       Date:  2007-03-16       Impact factor: 3.411

Review 5.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

6.  Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus.

Authors:  E Leich; E Hoster; M Wartenberg; M Unterhalt; R Siebert; K Koch; W Klapper; M Engelhard; B Puppe; H Horn; A M Staiger; C Stuhlmann-Laeisz; H W Bernd; A C Feller; M Hummel; D Lenze; H Stein; S Hartmann; M L Hansmann; P Möller; W Hiddemann; M Dreyling; G Ott; A Rosenwald
Journal:  Leukemia       Date:  2015-12-01       Impact factor: 11.528

7.  Primary pulmonary lymphoma in a patient with advanced AIDS.

Authors:  Lokesh Shahani; Megan McKenna
Journal:  BMJ Case Rep       Date:  2014-12-19

8.  Identification of the SOX5 gene as a novel IGH-involved translocation partner in BCL2-negative follicular lymphoma with t(12;14)(p12.2;q32).

Authors:  Masayuki Shiseki; Akihiro Masuda; Kentaro Yoshinaga; Naoki Mori; Michiko Okada; Toshiko Motoji; Junji Tanaka
Journal:  Int J Hematol       Date:  2015-06-27       Impact factor: 2.490

9.  High frequency of germinal centre derivation in diffuse large B cell lymphoma from Asian patients.

Authors:  A K H Shia; G-G Gan; S Jairaman; S-C Peh
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

10.  BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.

Authors:  Samantha L Kendrick; Lucas Redd; Andrea Muranyi; Leigh A Henricksen; Stacey Stanislaw; Lynette M Smith; Anamarija M Perry; Kai Fu; Dennis D Weisenburger; Andreas Rosenwald; German Ott; Randy D Gascoyne; Elaine S Jaffe; Elías Campo; Jan Delabie; Rita M Braziel; James R Cook; Raymond R Tubbs; Louis M Staudt; Wing Chung Chan; Christian Steidl; Thomas M Grogan; Lisa M Rimsza
Journal:  Hum Pathol       Date:  2014-06-26       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.